The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control

Overview

Journal Int J Hepatol

Publisher Wiley

Specialty Gastroenterology

Date 2012 Nov 8

PMID 23133759

Citations 26

Authors

Jean-Philippe Guegan

Christophe Fremin

Georges Baffet

Affiliations

Soon will be listed here.

Abstract

Primary cultures of hepatocytes are powerful models in studying the sequence of events that are necessary for cell progression from a G0-like state to S phase. The models mimic the physiological process of hepatic regeneration after liver injury or partial hepatectomy. Many reports suggest that the mitogen-activated protein kinase (MAPK) ERK1/2 can support hepatocyte proliferation in vitro and in vivo and the MEK/ERK cascade acts as an essential element in hepatocyte responses induced by the EGF. Moreover, its disregulation has been associated with the promotion of tumor cell growth of a variety of tumors, including hepatocellular carcinoma. Whereas the strict specificity of action of ERK1 and ERK2 is still debated, the MAPKs may have specific biological functions under certain contexts and according to the differentiation status of the cells, notably hepatocytes. In this paper, we will focus on MEK1/2-ERK1/2 activations and roles in normal rodent hepatocytes in vitro and in vivo after partial hepatectomy and in human hepatocarcinoma cells. The possible specificity of ERK1 and ERK2 in normal and transformed hepatocyte will be discussed in regard to other differentiated and undifferentiated cellular models.

Citing Articles

Differential Effects of the Processed and Unprocessed Garlic ( L.) Ethanol Extracts on Neuritogenesis and Synaptogenesis in Rat Primary Hippocampal Neurons.

Munni Y, Dash R, Choi H, Mitra S, Hannan M, Mazumder K Int J Mol Sci. 2023; 24(17).

PMID: 37686193 PMC: 10487397. DOI: 10.3390/ijms241713386.

System Biology Investigation Revealed Lipopolysaccharide and Alcohol-Induced Hepatocellular Carcinoma Resembled Hepatitis B Virus Immunobiology and Pathogenesis.

Patil V, Harish D, Sampat G, Roy S, Jalalpure S, Khanal P Int J Mol Sci. 2023; 24(13).

PMID: 37446321 PMC: 10342420. DOI: 10.3390/ijms241311146.

Electroacupuncture-Regulated miR-34a-3p/PDCD6 Axis Promotes Post-Spinal Cord Injury Recovery in Both and Settings.

Ma L, Ma L, Yang Y, Chen T, Wang L, Deng Q J Immunol Res. 2022; 2022:9329494.

PMID: 36132985 PMC: 9484976. DOI: 10.1155/2022/9329494.

Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line.

Atif M, Mustaan M, Falak S, Ghaffar A, Munir B Saudi J Biol Sci. 2022; 29(8):103332.

PMID: 35813116 PMC: 9256646. DOI: 10.1016/j.sjbs.2022.103332.

EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells.

He X, Hikiba Y, Suzuki Y, Nakamori Y, Kanemaru Y, Sugimori M Sci Rep. 2022; 12(1):8007.

PMID: 35568782 PMC: 9107466. DOI: 10.1038/s41598-022-12076-w.

References

Mitsui H, Takuwa N, Maruyama T, Maekawa H, Hirayama M, Sawatari T . The MEK1-ERK map kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int J Cancer. 2001; 92(1):55-62. View

Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F . Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 1999; 286(5443):1374-7. DOI: 10.1126/science.286.5443.1374. View

Fong C, Chua M, McKie A, Ling S, Mason V, Li R . Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res. 2006; 66(4):2048-58. DOI: 10.1158/0008-5472.CAN-05-1072. View

Campbell J, Argast G, Yuen S, Hayes B, Fausto N . Inactivation of p38 MAPK during liver regeneration. Int J Biochem Cell Biol. 2010; 43(2):180-8. PMC: 3022113. DOI: 10.1016/j.biocel.2010.08.002. View

McCarthy S, SAMUELS M, Pritchard C, Abraham J, McMahon M . Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 1995; 9(16):1953-64. DOI: 10.1101/gad.9.16.1953. View

Guo K, Liu Y, Zhou H, Dai Z, Zhang J, Sun R . Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion. Cancer Sci. 2008; 99(3):486-96. PMC: 11158944. DOI: 10.1111/j.1349-7006.2007.00702.x. View

Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D . V599EB-RAF is an oncogene in melanocytes. Cancer Res. 2004; 64(7):2338-42. DOI: 10.1158/0008-5472.can-03-3433. View

Challen C, Guo K, Collier J, Cavanagh D, Bassendine M . Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas. J Hepatol. 1992; 14(2-3):342-6. DOI: 10.1016/0168-8278(92)90181-n. View

Whittaker S, Marais R, Zhu A . The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010; 29(36):4989-5005. DOI: 10.1038/onc.2010.236. View

10.

Meloche S, Pouyssegur J . The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007; 26(22):3227-39. DOI: 10.1038/sj.onc.1210414. View

11.

Isom H, Secott T, Georgoff I, Woodworth C, Mummaw J . Maintenance of differentiated rat hepatocytes in primary culture. Proc Natl Acad Sci U S A. 1985; 82(10):3252-6. PMC: 397753. DOI: 10.1073/pnas.82.10.3252. View

12.

Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H . Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology. 2003; 38(4):820-8. DOI: 10.1053/jhep.2003.50399. View

13.

Marshall M . Ras target proteins in eukaryotic cells. FASEB J. 1995; 9(13):1311-8. DOI: 10.1096/fasebj.9.13.7557021. View

14.

Panteva M, Korkaya H, Jameel S . Hepatitis viruses and the MAPK pathway: is this a survival strategy?. Virus Res. 2003; 92(2):131-40. DOI: 10.1016/s0168-1702(02)00356-8. View

15.

Schrader J, Gordon-Walker T, Aucott R, van Deemter M, Quaas A, Walsh S . Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology. 2011; 53(4):1192-205. PMC: 3076070. DOI: 10.1002/hep.24108. View

16.

Rosseland C, Wierod L, Oksvold M, Werner H, Ostvold A, Thoresen G . Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes. Hepatology. 2005; 42(1):200-7. DOI: 10.1002/hep.20762. View

17.

Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C . Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem. 1996; 271(19):11484-92. DOI: 10.1074/jbc.271.19.11484. View

18.

Luo D, Gove C, Naomov N, Su J, Williams R . Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas. World J Gastroenterol. 2002; 4(2):97-99. PMC: 4688651. DOI: 10.3748/wjg.v4.i2.97. View

19.

Calvisi D, Pinna F, Meloni F, Ladu S, Pellegrino R, Sini M . Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res. 2008; 68(11):4192-200. DOI: 10.1158/0008-5472.CAN-07-6157. View

20.

Schuierer M, Bataille F, Weiss T, Hellerbrand C, Bosserhoff A . Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep. 2006; 16(3):451-6. View